Targeting MDS Stem Cells with Omacetaxine and Azacitidine for Newly Diagnosed High Grade Patients: Phase 1 Trial Results and Preliminary Mechanistic Studies

Brett M. Stevens, Daniel A. Pollyea, Craig T. Jordan et al.|Blood|2021

Cited by 0